D. E. Shaw & Co., Inc. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$5,675,918
+146.1%
351,450
+532.3%
0.01%
+200.0%
Q2 2023$2,306,737
+16.2%
55,584
+68.3%
0.00%0.0%
Q1 2023$1,985,642
+50.4%
33,017
+83.4%
0.00%
+100.0%
Q4 2022$1,320,300
+15.8%
18,000
+20.0%
0.00%0.0%
Q3 2022$1,140,000
+147.8%
15,003
+126.8%
0.00%0.0%
Q2 2022$460,000
-44.5%
6,614
-33.9%
0.00%0.0%
Q1 2022$829,000
-72.4%
10,000
-75.0%
0.00%
-50.0%
Q4 2021$3,003,000
-79.3%
40,000
-68.0%
0.00%
-84.6%
Q3 2021$14,524,000
-65.6%
125,016
-34.2%
0.01%
-64.9%
Q2 2021$42,168,000
+105.9%
190,101
+22.7%
0.04%
+94.7%
Q1 2021$20,477,000
+40.9%
154,916
+84.5%
0.02%
+46.2%
Q4 2020$14,530,000
+212.5%
83,966
+101.0%
0.01%
+160.0%
Q3 2020$4,650,000
+70.0%
41,779
-9.4%
0.01%
+66.7%
Q2 2020$2,736,000
-54.3%
46,136
-48.1%
0.00%
-66.7%
Q1 2020$5,987,000
-46.9%
88,921
-33.5%
0.01%
-30.8%
Q4 2019$11,268,000
-35.4%
133,713
-42.7%
0.01%
-40.9%
Q3 2019$17,455,000
-49.6%
233,420
-57.4%
0.02%
-48.8%
Q2 2019$34,611,000
+6.2%
547,375
-19.1%
0.04%
+2.4%
Q1 2019$32,605,000
+2172.1%
676,881
+1479.0%
0.04%
+2000.0%
Q4 2018$1,435,000
+31.2%
42,869
-14.6%
0.00%
+100.0%
Q1 2018$1,094,000
-17.9%
50,206
-23.8%
0.00%
-50.0%
Q4 2017$1,332,000
+151.8%
65,925
+115.5%
0.00%
+100.0%
Q2 2017$529,000
+445.4%
30,589
+156.7%
0.00%
Q1 2017$97,000
-66.8%
11,917
-68.0%
0.00%
Q4 2016$292,00037,2560.00%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders